A recent report by KD market insights titled as "Biopsy Devices Market Size, Trends &
Opportunity Outlook – Forecast to 2026" provides the key
trends, opportunities and challenges market will face in the forecasted period
of 6 years i.e. 2019-2026. The study also provides the Biopsy Devices Market. competitors share and region
wise analysis around the globe.
The global biopsy
devices market was valued at $2,728 million in 2018 and is expected to
reach $4,310 million by 2026, registering a CAGR of 5.9% during
the forecast period. Biopsy is a procedure to remove a sample of cells or piece
of tissue from living body to analyze it in a laboratory for diagnosis of
diseases. Biopsy tests are performed by surgeons, radiologists, and
interventional cardiologists. There are various types of biopsy devices used in
diagnosis of cancers, such as core biopsy devices, aspiration biopsy needles,
vacuum-assisted biopsy devices, biopsy forceps, localization wires, and others.
Core biopsy devices are used to investigate superficial lumps or masses for
diagnosis of cancer. In addition, vacuum-assisted biopsy devices and aspiration
biopsy needles are non–invasive and provide efficient sample collection.
Significant increase in
cancer incidence, advent of novel and minimally invasive biopsy procedures, and
rise in public awareness for disease screening are the major factors that drive
the growth of the biopsy devices market. In addition, rapid technological
advancements such as 3D optical biopsies, MRI-targeted biopsies, and ultrasound–guided
biopsies, and rise in awareness on diagnosis of chronic diseases are other
factors that contribute toward the growth of the market. In addition, surge in
adoption of biopsy devices across the globe boosts the growth of the biopsy
devices market. Furthermore, growth potential offered by developing economies
present lucrative opportunities for the growth of the market during the
forecast period. However, stiff competition from alternative cancer diagnostic
tests, and high cost and fluctuating reimbursement policies hinder the growth
of this market.
The biopsy devices market
is segmented on the basis of product, application, imaging technology, end
user, and region. Based on product, the market is divided into needle-based
biopsy instruments, biopsy forceps, localization wires, and other products.
Based on application, the market is categorized into breast biopsy,
gastrointestinal (GI) biopsy, prostate biopsy, liver biopsy, lung biopsy,
kidney biopsy, gynecological biopsy, and others. Based on imaging technology,
the market is divided into MRI-guided biopsy, stereotactic-guided biopsy,
ultrasound-guided biopsy, CT scan, and others. Based on end user, the market is
classified into diagnostic and imaging centers, hospitals, and others. Based on
region, the biopsy devices market size is analyzed across North America,
Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR
STAKEHOLDERS:
- The study provides an
in-depth analysis of the global biopsy devices market along with the current trends and future estimations
to elucidate the imminent investment pockets.
- Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2018 to 2026 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps in understanding the application and products of biopsy devices used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
- Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2018 to 2026 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps in understanding the application and products of biopsy devices used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS:
By Product
- Needle-Based Biopsy Instruments
- - - Core Biopsy Devices
- - - Aspiration Biopsy Needles
- - - Vacuum-Assisted Biopsy Devices
- Biopsy Forceps
- Localization Wires
- Other Products
- Needle-Based Biopsy Instruments
- - - Core Biopsy Devices
- - - Aspiration Biopsy Needles
- - - Vacuum-Assisted Biopsy Devices
- Biopsy Forceps
- Localization Wires
- Other Products
By Application
- Breast Biopsy
- Gastroenterology Biopsy
- Prostate Biopsy
- Liver Biopsy
- Lung Biopsy
- Kidney Biopsy
- Gynecological Biopsy
- Others
- Breast Biopsy
- Gastroenterology Biopsy
- Prostate Biopsy
- Liver Biopsy
- Lung Biopsy
- Kidney Biopsy
- Gynecological Biopsy
- Others
By Imaging Technologies
- MRI-guided Biopsy
- Stereotactic-guided Biopsy
- Ultrasound-guided Biopsy
- CT scan
- Others
- MRI-guided Biopsy
- Stereotactic-guided Biopsy
- Ultrasound-guided Biopsy
- CT scan
- Others
By End User
- Diagnostic & Imaging Centers
- Hospitals
- Others
- Diagnostic & Imaging Centers
- Hospitals
- Others
By Region
North America
- U.S.
- Canada
- Mexico
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Russia
- Spain
- Rest of Europe
- Germany
- France
- UK
- Russia
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY PLAYERS PRofILED:
- Argon Medical Devices,
Inc.
- B Braun Melsungen AG
- Becton Dickinson and Company (C. R. Bard, Inc.)
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Cook Medical, Inc.
- Danaher Corporation (Leica Microsystem)
- Fujifilm Holdings Corp.
- Hologic, Inc.
- B Braun Melsungen AG
- Becton Dickinson and Company (C. R. Bard, Inc.)
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Cook Medical, Inc.
- Danaher Corporation (Leica Microsystem)
- Fujifilm Holdings Corp.
- Hologic, Inc.
The other players in
the value chain include (profiles not included in the report) the following:
- Ethicon EndoSurgery Inc.
- Veran Medical Technologies
- MDxHealth
- Mauna Kea Technologies
- NuVue therapeutics, Inc.
- Veran Medical Technologies
- MDxHealth
- Mauna Kea Technologies
- NuVue therapeutics, Inc.
Get Complete Research Report
with TOC @: https://www.kdmarketinsights.com/product/5587/biopsy-devices-market-amr
Table Of Content:
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And
Models
Chapter 2: Executive
Summary
2.1. Key Findings of The
Study
2.2. Key Findings
2.2.1. Top Investment Pockets
2.3. Cxo Perspective
Chapter 3: Market
Overview
3.1. Market Definition And
Scope
3.2. Key Forces Shaping
Biopsy Devices Industry/Market
3.2.1. High Bargaining
Power of Supplier
3.2.2. Moderate Bargaining
Power of Buyers
3.2.3. High Threat of Substitutes
3.2.4. Low Threat of New
Entrant
3.2.5. Low Intensity of
Rivalry
3.3. Market Share Analysis
3.4. Value Chain Analysis
3.5. Industry Pain Point
Analysis
3.6. Market
Evolution/Industry Roadmap
3.7. Regulatory Norms
3.7.1. Regulatory Issues
of Gastroenterology And Urology Biopsy Devices In North America
3.7.2. Regulatory Scenario
For Breast Biopsy In European Union
3.8. Reimbursement
Scenario
3.8.1. Reimbursement For
Breast Cancer Screening In The U.S.
3.8.2. Reimbursement For
Breast Reconstruction Or Prosthesis
3.9. Patent Analysis
3.9.1. Patent Analysis, By
Country
3.9.2. Patent Analysis, By
Company
3.10. Case Studies
3.10.1. Case Study 01
3.10.2. Case Study 02
3.11. Market Dynamics
3.11.1. Top Impacting Factors
3.11.2. Drivers
3.11.2.1. Significant
Increase In Cancer Incidence
3.11.2.2. Advent of Novel
And Minimally Invasive Biopsy Procedures
3.11.2.3. Increasing
Public Awareness For Disease Screening
3.11.3. Restrains
3.11.3.1. Stiff
Competition From Alternative Cancer Diagnostic Tests
3.11.3.2. High Cost And
Fluctuating Reimbursement Policies
3.11.4. Opportunities
3.11.4.1. Tapping
Diagnostic Market Present In Emerging Economies
Chapter 4: Global
Biopsy Device Market, By Product
4.1. Overview
4.1.1. Market Size And
Forecast
4.2. Needle-Based Biopsy
Devices
4.2.1. Key Market Trends,
Growth Factors And Opportunities
4.2.2. Market Size And
Forecast, By Region
4.2.3. Market Analysis, By
Country
4.2.4. Market Size And
Forecast, By Type
4.2.5. Core Biopsy Devices
4.2.5.1. Market Size And
Forecast
4.2.6. Aspiration Biopsy
Needles
4.2.6.1. Market Size And
Forecast
4.2.7. Vacuum–Assisted
Biopsy (Vab) Devices
4.2.7.1. Market Size And
Forecast
4.3. Biopsy Forceps
4.3.1. Key Market Trends,
Growth Factors And Opportunities
4.3.2. Market Size And
Forecast
4.3.3. Market Analysis, By
Country
4.4. Localization Wires
4.4.1. Key Market Trends,
Growth Factors And Opportunities
4.4.2. Market Size And
Forecast
4.4.3. Market Analysis, By
Country
4.5. Other Products
4.5.1. Key Market Trends,
Growth Factors And Opportunities
4.5.2. Market Size And
Forecast
4.5.3. Market Analysis, By
Country
Chapter 5: Global
Biopsy Devices Market, By Application
5.1. Overview
5.1.1. Market Size And
Forecast
5.2. Breast Biopsy
5.2.1. Market Size And
Forecast
5.2.2. Market Analysis, By
Country
5.3. Gastroenterology
Biopsy
5.3.1. Market Size And
Forecast
5.3.2. Market Analysis, By
Country
5.4. Prostate Biopsy
5.4.1. Market Size And
Forecast
5.4.2. Market Analysis, By
Country
5.5. Liver Biopsy
5.5.1. Market Size And
Forecast
5.5.2. Market Analysis, By
Country
5.6. Lung Biopsy
5.6.1. Market Size And
Forecast
5.6.2. Market Analysis, By
Country
5.7. Kidney Biopsy
5.7.1. Market Size And
Forecast
5.7.2. Market Analysis, By
Country
5.8. Gynaecological Biopsy
5.8.1. Market Size And
Forecast
5.8.2. Market Analysis, By
Country
5.9. Others
5.9.1. Market Size And
Forecast
5.9.2. Market Analysis, By
Country
Chapter 6: Global
Biopsy Device Market, By Imaging Technology
6.1. Overview
6.1.1. Market Size And
Forecast
6.2. Mri–Guided Biopsy
6.2.1. Market Size And
Forecast
6.2.2. Market Analysis, By
Country
6.3. Stereotactic–Guided
Biopsy
6.3.1. Market Size And
Forecast
6.3.2. Market Analysis, By
Country
6.4. Ultrasound–Guided
Biopsy
6.4.1. Market Size And
Forecast
6.4.2. Market Analysis, By
Country
6.5. Ct Scan
6.5.1. Market Size And
Forecast
6.5.2. Market Analysis, By
Country
6.6. Others
6.6.1. Market Size And
Forecast
6.6.2. Market Analysis, By
Country
Chapter 7: Global
Biopsy Devices Market, By End Users
7.1. Overview
7.1.1. Market Size And
Forecast
7.2. Diagnostic And
Imaging Centers
7.2.1. Market Size And
Forecast
7.2.2. Market Analysis, By
Country
7.3. Hospitals
7.3.1. Market Size And
Forecast
7.3.2. Market Analysis, By
Country
7.4. Others
7.4.1. Market Size And
Forecast
7.4.2. Market Analysis, By
Country
Continue:
About Us:
KD Market Insights offers a comprehensive database of syndicated
research studies, customized reports, and consulting services. These reports
are created to help in making smart, instant and crucial decisions based on
extensive and in-depth quantitative information, supported by extensive
analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement
of the client. We aim at providing value service to our clients. Our reports
are backed by extensive industry coverage and is made sure to give importance
to the specific needs of our clients. The main idea is to enable our clients to
make an informed decision, by keeping them and ourselves up to date with the
latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12607
Telephone: +1 (520) 300-1215
No comments:
Post a Comment